logo
Ataxia rating scales in the balance
Shortage of human intravenous immunoglobulin-reasons and possible solutions
Granulocyte-colony-stimulating factor; an effective treatment following stroke?
Activated protein C could prevent hemorrhage during thrombolytic therapy for stroke
Novel MRI contrasts measure in vivo characteristics of Parkinson's disease
Inhibiting the DNA damage checkpoint response might prevent recurrence in glioblastoma
Cholinesterase inhibitors potentiate memantine neurotoxicity
Automated MRI measurements accurately identify clinically probable Alzheimer's disease
Symptoms of depression are an independent risk factor for stroke in the under 65s
In vivo study demonstrates potential of blocking apoE/Aβ in Alzheimer's disease
Neurotoxicity of chemotherapy
Status epilepticus of vascular origin results in high mortality
Transcranial magnetic stimulation for the relief of chronic pain
Carotid plaque surface irregularities increase risk of ischemic stroke
Long-term follow-up of a risk-adapted protocol for children with medulloblastoma
Which EEG protocol is best in young adults with possible epilepsy?
Statin therapy after stroke or transient ischemic attack-a new weapon in our secondary stroke prevention arsenal?
Revised criteria for neuromyelitis optica-a new diagnostic standard?
Diagnosing psychogenic movement disorders-which criteria should be used in clinical practice?
SARA-a new clinical scale for the assessment and rating of ataxia
Validation of a neurological-exam-based rating scale (FARS) for Friedreich's ataxia
X-linked adrenoleukodystrophy
Olfactory ensheathing cell transplantation as a strategy for spinal cord repair-what can it achieve?
Mechanisms of Disease: DNA repair defects and neurological disease
Urgent intervention to reduce functional deficits after postoperative stroke